Viewing nowAprogen Risedronate Sodium 150 mg Tablets (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Aprogen Biosciences, Co., Ltd.

MFDS item code 201004245 · Approved 2010.06.30 · Insurance code 645207300
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to treat and prevent osteoporosis that may occur in postmenopausal women. Osteoporosis is a condition characterized by weakened bones, increasing the risk of fractures, and this medication strengthens the bones to reduce the risk of fractures. Therefore, it is suitable for those who wish to maintain bone health after menopause.
1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Elderly patients : No dose adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. To ensure adequate absorption, take it at least 30 minutes before the first food or beverage other than water consumed that day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled dosing day, follow these instructions. - If 7 days or more remain until the next scheduled dose, take 1 tablet the morning after remembering. Take the next dose on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If fewer than 7 days remain until the next scheduled dose, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
The safety and efficacy of this medicine in children under 18 years of age have not been established.
This medication may irritate the stomach and esophagus mucosa, so patients with gastritis or esophageal diseases must be cautious when taking it. Especially in cases of esophageal problems or difficulty swallowing, medication should be discontinued and a doctor consulted. It's essential to take this medication with a sufficient amount of water and avoid lying down for at least 30 minutes after taking it. Because this medication can irritate the esophagus, it should not be chewed or sucked on, and it is recommended to take it immediately upon waking in the morning. The effectiveness of this medication may decrease when calcium and vitamin D levels are insufficient, so proper intake of calcium and vitamin D is important. Women who are pregnant or may become pregnant, patients with severe renal impairment, and patients with esophageal motility disorders should not take this medication. This medication should also not be administered to patients with certain hereditary diseases, and care should be taken to store it safely away from children. If symptoms of sudden thigh pain or fracture occur while taking this medication, consult a doctor immediately. Rare side effects such as osteonecrosis of the jaw may occur, so oral health care should be prioritized, and prior consultation with a doctor is necessary before dental treatment. When taken with other medications, absorption may be hindered; therefore, it should be taken at a sufficient time interval from calcium or antacid products. In case of overdose, blood calcium levels may drop, and immediate treatment is required if symptoms appear. This medication has not been shown to be safe and effective in children, so it should not be used in this population. Always carefully read the product information leaflet and take as instructed by your doctor.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is airtight and kept at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent degradation.
Bright blue rectangular film-coated tablet
1 tablet/PTP × 1
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Aprogen Biosciences, Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.